During chemically induced differentiation of Friend virus-infected mouse erythroleukemia (MEL) cell lines, there is a biphasic down-regulation of the c-myb proto-oncogene. A plasmid containing a murine c-myb cDNA controlled by a mouse metallothionein I promoter was transfected into the C19 MEL cell line. For six transfected clones, it was found that expression of the exogenous c-myb mRNA could be up-regulated by the addition of 120 FIM ZnCl2 and that the N,N'-hexamethylenebisacetamide-induced differentiation of these transfectants was inhibited in proportion to the level of exogenous c-myb mRNA expression. By adding or removing ZnC12 at different times during the induction process, it was possible to show that up-regulation of exogenous c-myb limited to the first 2 days of induction had little or no effect on differentiation. In contrast, continuous expression of exogenous c-myb beginning at any time during the period of induction blocked further differentiation. These results suggest that during HMBA induction of MEL cells, the early down-regulation of c-myb mRNA is not necessary for terminal differentiation, whereas the down-regulation of c-myb at a later time is necessary.
Friend virus-infected mouse erythroleukemia (MEL) cell lines provide an early erythroid precursor model system that can be induced to differentiate into more mature erythroid cells (6, 18) . Some of these cell lines can be induced with natural factors such as erythropoietin, but most of the cell lines are responsive only to a chemical inducer such as dimethyl sulfoxide (DMSO) or N,N'-hexamethylenebisacetamide (HMBA). When inducer is added, there is a latent period of approximately 12 h before cells stochastically become irreversibly committed to a terminal differentiation program during the next few days (8) . After the commitment process, the cells increasingly express hemoglobin and other mature erythroid markers while undergoing several rounds of cell proliferation before a terminal cell division.
Little is known about the events that regulate hematopoietic differentiation. However, both the c-myc and c-myb mRNAs are down-regulated biphasically during chemically induced MEL differentiation (11, 14, 21) . After addition of the inducer, both mRNAs are markedly down-regulated within hours but are then reexpressed at nearly basal (i.e., preinduction) levels during the first 24 h of induction. During the next several days, both genes are again down-regulated, with maximum down-regulation of both genes occurring as cells become terminally differentiated. On the basis of changes in the expression of c-myb and c-myc mRNAs, the differentiation of MEL cells can be divided into three stages, early, middle, and late. Among the earliest known cellular responses during induction of MEL cells are the rapid down-regulation of c-myb and c-myc mRNAs. The beginning of the middle stage of differentiation is marked by the return of c-myb and c-myc mRNAs to nearly basal levels. The expression of c-myc mRNA is restricted primarily to the late G, period of the cell cycle at this time, although the expression of c-myc mRNA is essentially cell cycle independent in uninduced MEL cells (16) . The cell cycle regulation of c-myb mRNA has not been reported in this system. During the late stage of differentiation, as the terminally * Corresponding author. differentiated cells stop dividing, c-myb and c-myc mRNAs are again expressed at levels substantially below preinduction levels.
We and others have shown that the continuous expression of either a transfected c-myc or c-myb gene prevents the terminal differentiation process (3-5, 12, 13, 15, 20, 23) . By transfecting an inducible, metallothionein promoter-driven c-myb gene into MEL cells, this study attempts to determine at what time or times during induction c-myb down-regulation is necessary for terminal differentiation.
MATERIALS AND METHODS
Plasmid construction. A plasmid (pMTHfos) containing (i) the mouse metallothionein I promoter, (ii) a genomic segment including the 3' end of exon 2, intron 2, exon 3, and 3'-flanking sequences of the human ,B-globin gene, and (iii) an SV40-Neo selectable marker was obtained from Jeffrey Holt (Vanderbilt University). This plasmid was constructed by cloning the EcoRI-BglII mouse metallothionein I promoter region (9) into pUC-9 and then isolating this sequence as an EcoRI-HindIII fragment, which was used to replace the EcoRI-HindlIl mouse mammary tumor virus sequence in the pHfos vector (10) . The mouse c-myb cDNA fragment, including sequences between the SmaI site at position 230 (which was converted to a HindIII site with linkers) and the BglII site at position 2333 (1), was substituted for the HindIII-BamHI fos fragment in pMTHfos, resulting in the pMTH.Myb vector.
Cell culture. A thymidine kinase-negative clone (C19) derived from the Friend leukemia virus MEL cell line 745 was used as a recipient for most transfection experiments (6) . In several intances, a C19 clone (G6.0) that had been transfected previously with pRSV.Mb.TK and expresses low levels of exogenous c-myb mRNA was secondarily transfected with the pMTH.Myb vector (12) . Cells and transfectants were maintained in growth medium (RPMI 1640 supplemented with 5% fetal bovine serum plus penicillin and streptomycin). The C19 parental cell line and derivative transfectants had generation times of approximately 24 h for all growth conditions described in this report. Cell viability was determined by trypan blue exclusion.
Differentiation assay. Approximately 6 h before induction, logarithmically growing cells were plated at 105/ml in growth medium containing 10% fetal bovine serum (Hyclone). Induction was initiated by the addition of 0.006 volumes of 0.5 M HMBA (Sigma Chemical Co.), resulting in medium containing HMBA at a final concentration of 3 mM. Depending on the rate of cell growth, the induced cultures were diluted two-to fourfold with induction medium containing 3 mM HMBA at some time during the 5-day period of induction. At various times during the induction, cells were removed and scored for hemoglobin expression, as determined by benzidine staining of individual cells (6) . Typically, 75 to 90% of the control cells (C19) were benzidine positive after 5 days of induction, but occasionally as few as 60% of the cells were benzidine positive at this time.
Transfections. Transfections were performed either by a CaPO4 technique (5, 7) or by electroporation (19) . The day after the transfection was initiated, cells were plated in growth medium at 0.5 x 105 to 1 x 105 live cells per ml per well in a 24-well macrodilution plate (Costar). The next day, selection was started by adding to each well 1 ml of growth medium containing G418 (GIBCO Laboratories), resulting in a final concentration of 400 ,ug of G418 per ml. Two to three weeks later, transfectants were grown up and maintained in growth medium containing 200 jig of G418 per ml. Only one spontaneous G418-resistant mutant occurred when 5 x 107 control cells were plated. Transfection frequencies varied from 0 to 5 per 107 cells plated. Curiously, both methods generated G418-resistant transfectants with use of circular plasmid, whereas only the CaPO4 method generated G418-resistant transfectants with use of EcoRV-linearized plasmid.
RNA analysis. Total RNA was isolated by ultracentrifugation of guanidine thiocyanate cell lysates through cesium chloride gradients (2) . The RNA was fractionated on 1% agarose gels containing 0.22 M formaldehyde and transferred to nitrocellulose filters (17) . Probes for hybridization included a 2.4-kilobase (kb) EcoRI murine c-myb cDNA fragment, a 1.5-kb EcoRI-ClaI human c-myc genomic fragment containing most of exon 3, and a 3.3-kb SstI murine at-globin fragment (1, 5, 11) . The filters were hybridized, washed, and exposed to XAR-5 or XRP film at -70°C with intensifying screens as described previously (1, 22) . In some cases, filters were sequentially hybridized with up to four different probes, with residual probe from a prior hybridization being stripped by washing the filter at 95°C in 0.1x SSC-0.1% sodium dodecyl sulfate (SSC is 0.15 M NaCl plus 0.015 M sodium citrate).
RESULTS
The pMTH.Myb vector was transfected both into C19 cells and into clone G6.0, which expresses exogenous c-myb mRNA at a level approximately 20% of the endogenous level. Of 26 transfectants isolated from five different transfection experiments, 19 expressed the expected 2.7-kb exogenous c-myb mRNA. In all cases, expression of the exogenous c-myb mRNA was significantly enhanced by the addition of 30 ,uM CdCl2 (9) . Figure 1 illustrates six examples of transfectants that expressed exogenous c-myb mRNA plus two examples of transfectants (clones 39-3 and 67-1) that did not. Two of these transfectants (clones C1 and D3) were derived from the G6.0 clone, and the remainder were derived from the parental C19 clone. In each case, there was confirmed that all lanes contained approximately equal amounts of RNA. The portions of film demonstrating expression of the relevant mRNAs is shown: 3.8-kb endogenous and 2.7-kb exogenous c-myb, 2.4-kb c-myc, and 0.6-kb a-globin. exogenous c-myb (clone 67-1) was induced with HMBA, either with or without added ZnCl2, the patterns of mRNA expression were similar to those published previously for control cells (5) . After HMBA addition at time zero, there was a rapid decrease in c-myc mRNA expression (1 h), followed by a decrease in c-myb mRNA (4 h). Late in the induction process (120 h), there was a marked increase in a-globin mRNA, little or no detectable c-myb mRNA, and a significant decrease in c-myc mRNA compared with the basal, pre-induction level.
For the other transfectants (clones 39-6 and 39-7), the exogenous c-myb mRNA was expressed at an essentially constant level both early (1 and 4 h) and late (120 h) during the course of HMBA induction in the presence of ZnCl2. These two transfectants were blocked almost completely in their ability to differentiate during HMBA induction in the presence of 120 ,uM ZnCl2 (0 and 7% benzidine-positive cells, respectively, after 5 days of induction), yet the early down-regulation of c-myc and endogenous c-myb was similar to that for the control cells. However, the late (120 h) down-regulation of c-myc and endogenous c-myb seen for control cells was not apparent when these two transfectants were prevented from differentiating as a result of the high levels of exogenous c-myb mRNA induced by ZnCl2. This result is essentially identical to that reported by Clarke et al. (3) for transfectants that are prevented from terminal differentiation because of the constitutive expression of exogenous human c-myb mRNA. In addition, late up-regulation of a-globin mRNA was diminished, in parallel with the de- creased fraction of benzidine-positive cells, for both transfectants (Fig. 2) .
Induction of transfectants 39-6 and 39-7 with HMBA for 5 days in the absence of added ZnCl2 resulted in 22 and 45% benzidine-positive cells, respectively. The expression patterns of c-myc, endogenous c-myb, and a-globin mRNAs under these conditions were roughly intermediate between the patterns for these same transfectants induced in the presence of ZnCl2 and control cells.
The kinetics by which benzidine-positive cells were generated during induction with 3 mM HMBA, both without and with the addition of 120 p.M ZnCl2 during the period of induction, are shown for three transfectants in Fig. 3 . For the control transfectant (clone 67-1), there was a significant number of benzidine-positive cells by day 2, with peak or near-peak levels being reached by day 4 in different experiments. The addition of ZnCl2 had no consistent effect on this result. In the absence of added ZnCl2, clones CM2 and 39-7 generated benzidine-positive cells at a slower rate, although in the experiment shown in Fig. 3 the maximum percentage of benzidine-positive cells was only slightly different from that of the 67-1 control transfectant when assayed at day 5. In the presence of added ZnCl2, there was a marked decrease in the fraction of benzidine-positive cells at all time points for both the CM2 and 39-7 transfectants.
We next determined the times at which the up-regulation of exogenous c-myb mRNA would inhibit the differentiation process (Fig. 4) . For the control transfectant (clone 67-1), it was confirmed that the generation of benzidine-positive cells was not significantly affected by the addition of 120 p.M ZnCl2 at any time during the 5-day induction. In contrast, for clones CM2 and 39-7, there was a marked inhibition of the generation of benzidine-positive cells (assayed after 5 (Fig. 4B) were similar. We considered the possibility that the results of ZnCl2 addition (Fig. 4) We then determined whether an early drop in c-myb mRNA levels is necessary for generation of benzidinepositive cells by HMBA induction. Transfectants were induced with HMBA in the presence of 120 puM ZnCl2, and then ZnCl2 was removed at various times during the period of induction (Fig. 5) . For the control transfectant (67-1), it was again confirmed that the absence or presence of ZnCl2 had no effect on the generation of benzidine-positive cells during HMBA induction. In contrast, transfectants CM2 and 39-7 were markedly and similarly affected by the removal of ZnCl2. When ZnCl2 was removed 1 day after HMBA was added, the fraction of benzidine cells at day 5 was only slightly diminished compared with the fraction in a parallel culture that was induced with HMBA in the absence of added ZnCl2 (zero time point). The inhibitory effect of ZnCl2 on the generation of benzidine-positive cells appeared to be reversed with decreasing efficiency as ZnCl2 was removed later and later in the time course. This effect is explained at least partially by the experimental design in that benzidinepositive cells were assessed at day 5. In other words, the later ZnCl2 is removed, the less time is available for reversal of the ZnCl2 inhibitory effect. The results in Table 1 support this explanation, since more reversal of the inhibitory effect was evident for the day 3 and day 4 time points of ZnCl2 or 18 h after the addition of 120 F.M ZnC12 to the culture. On days 3 and 4 after the addition of HMBA, the ZnC12 was removed from portions of the culture and the cells were refed with medium containing HMBA as described in the legend to Fig. 5 . On days 3 through 7, a sample of cells was removed from each of the four cultures to determine the percentage of benzidine-positive cells. ND, Not determined.
removal from transfectant CM2 if the fraction of benzidinepositive cells was assessed at day 6 or day 7 of HMBA induction; similar results were obtained for the independent 39-7 transfectant (data not shown). The interpretation of the data in Table 1 is somewhat complicated by the fact that there was a decreased fraction of benzidine-positive cells in the control culture at days 6 and 7 compared with day 5, presumably because of the decreased proliferation rate of benzidine-positive compared with benzidine-negative cells during this time interval. The results in Fig. 5 and Table 1 indicate that the early down-regulation of c-myb mRNA is not necessary for the induction of differentiation by HMBA. DISCUSSION This report confirms results published previously by ourselves and others that expression of a transfected c-myb cDNA blocks chemically induced differentiation of MEL cells (3, 12, 23) . The inhibition is seen with two independent murine c-myb cDNA clones and a human c-myb cDNA clone, suggesting that the inhibition is mediated by expression of a normal c-myb transcript. As noted previously, this provides the only current assay for assessing the function of a normal c-myb gene (3) . The inhibition is seen both with DMSO and HMBA chemical induction and with the more physiological induction mediated by erythropoietin. The extent of inhibition is proportional to the level of exogenous c-myb mRNA expression, with significant inhibition of differentiation occurring when the basal level of exogenous c-myb mRNA approaches the basal level of endogenous c-myb mRNA. Induction of increased expression of exogenous c-myb mRNA by incubation of an appropriate transfectant with methotrexate or heavy metals results in a decreased ability of that clone to differentiate. Conversely, variant clones that no longer express exogenous c-myb mRNA (or express it at a much lower level than does the original transfectant clone) regain the ability to differentiate. These results for c-myb transfectants are virtually the same as results on c-myc transfectants (4, 5, 13, 20 (Fig. 4) . Conversely, the inhibitory effect of 120 p.M ZnCl2 on differentiation is (i) almost fully reversed if the ZnCl2 is removed during the first 24 h of HMBA induction and (ii) partially reversed even if the ZnCl2 is removed as late as 4 days after addition of HMBA ( Fig. 5 and Table 1 ). Together, these results suggest that the early down-regulation of c-myb is not necessary for HMBA-induced differentiation, whereas the down-regulation of c-myb at a later time is necessary for HMBA-induced differentiation of MEL cells.
Using a similar approach, others have recently reported that the early down-regulation of c-myc is not necessary for DMSO-induced differentiation, whereas the down-regulation of c-myc at a later time is necessary for DMSO-induced differentiation of MEL cells (13) . This result seemed surprising, since the late down-regulation of c-myc often is much less pronounced than the late down-regulation of c-myb during DMSO-or HMBA-induced differentiation of MEL cells (11, 12) . However, we have recently substituted a c-myc cDNA for c-myb in the pMTH.Myb vector and have done preliminary experiments that support the conclusion that the early down-regulation of c-myc mRNA is not necessary for HMBA-induced differentiation, whereas the down-regulation of c-myc at a later time is necessary for HMBA-induced MEL differentiation (C. Timblin, L. Brents, and M. Kuehl, unpublished data). As further support for this conclusion, it has been reported that during the induction of MEL cells by DMSO, the initial phase of c-myc mRNA down-regulation is not accompanied by a decreased expression of c-myc protein (24) . In addition, it was recently reported that erythropoietin induction of MEL cell differentiation results in an early up-regulation, followed by a late down-regulation of c-myc mRNA, even though there is a biphasic down-regulation of c-myb mRNA during erythropoietin induction (23) .
Transfectants that express exogenous c-myb mRNA at a level sufficient to cause an essentially complete block of chemically induced differentiation display certain notable features (3; this report). First, the initial down-regulation and subsequent recovery of endogenous c-myb and c-myc mRNA levels is essentially the same for control cells and myb transfectants. Second, in contrast to control cells, the terminal down-regulation of c-myb and c-myc mRNA levels does not occur for the myb transfectants. Third, the upregulation of a-globin mRNA is substantially and perhaps completely blocked in myb transfectants that do not generate any benzidine-positive cells during chemical induction (e.g., Fig. 2 , clone 39-6 + ZnCl2). Finally, the myb tranfectants continue to proliferate, whereas control cells no longer proliferate after 5 days of chemical induction. All of these properties have been observed for transfectants that are prevented from terminal differentiation as a result of expression of an exogenous c-myc gene (4, 5, 13, 20) . Thus, it is not possible to infer a sequence for the effects of c-myb and VOL. 10, 1990 709 on January 25, 2018 by guest http://mcb.asm.org/ Downloaded from c-myc in the chemically induced differentiation of MEL cells.
It is striking that the terminal down-regulation of endogenous c-myb and c-myc mRNAs does not occur in MEL transfectants that are unable to differentiate because of continued expression of exogenous c-myb or c-myc mRNA (e.g., 120-h time point in Fig. 2; 3, 5, 20) . Apparently, a secondary decrease in c-myb and c-myc mRNA expression is necessary both for differentiation and for the terminal down-regulation of the endogenous c-myb and c-myc genes. Alternatively, it is important to consider the possibility that the expression of an exogenous c-myb mRNA has some effect other than negating a secondary decrease in endogenous c-myb mRNA expression. For example, it might be postulated that increased expression of c-myb serves as a proliferative stimulus to uncommitted cells. However, this is unlikely, since the growth rates of transfectants are independent of the level of expression of exogenous c-myb mRNA regardless of whether rates of cell growth are determined in the presence or absence of ZnCl2 or HMBA (L. Brents and M. Kuehl, unpublished data). Single-cell commitment assays (15, 18) might help to more precisely define the effects of exogenous c-myb (or c-myc) on MEL cell differentiation. However, we have been unable to attain high efficiency of cloning for commitment assays done with the C19 parental clone and our transfectants in the presence of ZnCl2 and HMBA.
Although it appears that the relatively late down-regulation of both the c-myb and c-myc oncogenes is necessary for terminal differentiation of MEL cells, the mechanism(s) by which these genes act remains obscure. The availability of transfectants that express these genes, either constitutively or under control of the inducible metallothionein promoter, should aid us both in clarifying how these genes regulate differentiation and in identifying other genes that affect differentiation in the MEL cell model.
